Shiga Toxin Targets the Podocyte in Haemolytic Uraemic Syndrome (HUS) Resulting in Glomerular Endothelial Cell Complement Dysregulation

被引：0
|
作者：
Bowen, Emily E. [1 ]
Hurcombe, Jenny [1 ]
Keir, Lindsay S. [1 ]
Barrington, Fern [1 ]
Farmer, Louise K. [1 ]
Lay, Abigail C. [1 ]
Welsh, Gavin I. [1 ]
Larkai, Eva [1 ]
Saleem, Moin [1 ]
Coward, Richard [1 ]
机构：
[1] Univ Bristol, Fac Hlth Sci, Bristol Renal, Bristol, Avon, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO1717
引用
收藏
页码：533 / 534
页数：2
相关论文
共 50 条
  • [1] SHIGA TOXIN TARGETS THE PODOCYTE IN HAEMOLYTIC URAEMIC SYNDROME (HUS) RESULTING IN GLOMERULAR ENDOTHELIAL CELL COMPLEMENT DYSREGULATION
    Bowen, Emily
    Hurcombe, Jenny
    Barrington, Fern
    Keir, Lindsay
    Farmer, Louise
    Lay, Abigail
    Larkai, Eva
    Welsh, Gavin
    Saleem, Moin
    Coward, Richard
    PEDIATRIC NEPHROLOGY, 2022, 37 (11) : 2805 - 2806
  • [2] Lack of Complement Factor H Contributes to Endothelial Cell Injury in Shiga Toxin Haemolytic Uraemic Syndrome
    Bowen, Emily E.
    Hurcombe, Jenny
    Barrington, Fern
    Farmer, Louise K.
    Ortiz-Sandoval, Carolina G.
    Bruno, Valentina
    Shirazi, Niyousha Rostam
    Welsh, Gavin I.
    Licht, Christoph
    Saleem, Moin
    Coward, Richard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 518 - 518
  • [3] Complement dysregulation in haemolytic uraemic syndrome
    Bonnardeaux, A
    Pichette, V
    LANCET, 2003, 362 (9395): : 1514 - 1515
  • [4] Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome
    Keir, Lindsay S.
    Saleem, Moin A.
    PEDIATRIC NEPHROLOGY, 2014, 29 (10) : 1895 - 1902
  • [5] Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome
    Lindsay S. Keir
    Moin A. Saleem
    Pediatric Nephrology, 2014, 29 : 1895 - 1902
  • [6] Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation
    Bowen, Emily E.
    Hurcombe, Jennifer A.
    Barrington, Fern
    Keir, Lindsay S.
    Farmer, Louise K.
    Wherlock, Matthew D.
    Ortiz-Sandoval, Carolina G.
    Brun, Valentina
    Bohorquez-Hernandez, Arlette
    Diatlov, Daniel
    Rostam-Shirazi, Niyousha
    Wells, Sara
    Stewart, Michelle
    Teboul, Lydia
    Lay, Abigail C.
    Butler, Matthew J.
    Pope, Robert J. P.
    Larkai, Eva M. S.
    Morgan, B. Paul
    Moppett, John
    Satchell, Simon C.
    Welsh, Gavin I.
    Walker, Patrick D.
    Licht, Christoph
    Saleem, Moin
    Coward, Richard J. M.
    MED, 2023, 4 (11): : 761 - +
  • [7] Treating Shiga toxin induced haemolytic uraemic syndrome
    Artunc, Ferruh
    BRITISH MEDICAL JOURNAL, 2012, 345
  • [8] Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
    Patrick R. Walsh
    Sally Johnson
    Pediatric Nephrology, 2019, 34 : 1485 - 1492
  • [9] Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
    Walsh, Patrick R.
    Johnson, Sally
    PEDIATRIC NEPHROLOGY, 2019, 34 (09) : 1485 - 1492
  • [10] EVIDENCE FOR COMPLEMENT DYSREGULATION IN PNEUMOCOCCAL HAEMOLYTIC URAEMIC SYNDROME
    Johnson, S. A.
    Williams, J. M.
    Morgan, B.
    Taylor, C.
    Savage, C. O. S.
    PEDIATRIC NEPHROLOGY, 2009, 24 (09) : 1781 - 1781
12345